IONS - Ionis angioedema drug shows positive results in Phase 3 trial
2024-01-22 08:00:31 ET
More on Ionis Pharmaceuticals
- Ionis Pharmaceuticals: Pioneering Precision Medicine
- Ionis Pharmaceuticals, Inc. (IONS) Q3 2023 Earnings Call Transcript
- Ionis Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation
- FDA approves AstraZeneca, Ionis drug for ATTRv-PN
- Ionis says Angelman syndrome drug well tolerated in study
For further details see:
Ionis angioedema drug shows positive results in Phase 3 trial